Assisted Reproduction Registries and Reporting
RRM Academy Synopsis
Ontario births after ART were preterm 14.1% versus 7.4% without
About 14 in 100 births after ART were preterm, against about 7 in 100 without, among Ontario births from 2013 to 2021 in this Canadian ART registry summary. The slides also report 2022 cycle outcomes from 33 clinics, embryo testing and cumulative results.
Key Findings
- Among Ontario births from 2013 to 2021, preterm birth (under 37 weeks) occurred in 14.1% after ART and 7.4% without ART. The adjusted risk ratio was 1.82 (95% CI 1.76−1.87).
- Among Ontario singleton births from 2013 to 2021, preterm prevalence was 9.7% after ART and 6.6% without ART. The adjusted risk ratio was 1.42 (95% CI 1.36−1.47).
- In Ontario, ART preterm prevalence was 19.0% for births in 2013 to 2015 and 12.9% for 2016 to 2021. Non-ART prevalence was 7.2% and 7.5% in the same periods.
- In 2022, clinical pregnancy followed 43.3% of 18,119 frozen embryo transfers with own oocytes and 32.6% of 4,164 fresh IVF embryo transfers with own oocytes.
- Male factor appeared among the reasons listed for 24.8% of 2022 IVF cycle starts and unexplained infertility for 21.8%. Categories overlapped, since a cycle could carry more than one reason.
Interpretation
These conference slides summarize clinic-submitted data from a national registry. The authors state that no formal statistical tests were carried out, so comparisons between treatment cycles, patients or embryo transfers call for caution. The preterm comparison uses Ontario births and adjusts only for maternal age at delivery. The slides give no reason for the gap between ART and non-ART births. The 2022 cycle figures come from 33 clinics, and the birth outcomes for 2021 cycle starts from 35.
RRM Context
Restorative reproductive medicine looks for the cause of infertility in both partners. The registry lists male factor and unexplained infertility among the common reasons for ART cycles. Unexplained infertility means the cause is undiagnosed. ART bypasses the reproductive system without resolving why conception fails. The registry also reports more preterm births after ART.
Abstract
These slides from the Canadian Assisted Reproductive Technologies Register Plus (CARTR Plus) were presented at the Canadian Fertility and Andrology Society 69th Annual Meeting in Toronto, September 20 to 23, 2023. The slides report treatment cycle outcomes for 2022 cycle starts, based on 33 clinics, and birth outcomes for 2021 cycle starts, based on 35 clinics. Further sections cover trends over time, preimplantation genetic testing, cumulative pregnancy and live birth rates, the Ontario Fertility Program and gestational age at time of delivery. For Ontario births from 2013 to 2021, the slides report a preterm birth prevalence of 14.1% after ART, compared with 7.4% for non-ART births, with an adjusted risk ratio of 1.82.
Read the guide
-
ART Registries and Codes of Practice: A Reference for Patients and Clinicians
A global reference to national IVF registries (HFEA, RTAC, ANZARD, Q-IVF, CDC, DIR, JSOG, CARTR Plus, REDLARA, ESHRE EIM, ICMART) and the codes of practice that govern fertility clinics. What each measures, and what they miss.


